Efficacy of canakinumab as first-line biologic agent in adult-onset Still's disease

Fulltext present in this item

Fulltext: 202901.pdf

Format: PDF

Description: publisher's version

Title:	Efficacy of canakinumab as first-line biologic agent in adult-onset Still's disease
Author(s):	Cavalli, G.C.; Tomelleri, A.; Luca, G. De; Campochiaro, C.; Dinarello, C.A. ; Baldissera, E.; Dagna, L.
Publication year:	2019
Source:	Arthritis Research & Therapy, vol. 21, iss. 1, (2019), pp. 54
ISSN:	1478-6354
DOI:	https://doi.org/10.1186/s13075-019-1843-9
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : http://hdl.handle.net/2066/202901
Display more details
Subject:	Radboudumc 4: lnfectious Diseases and Global Health RIMLS: Radboud Institute for Molecular Life Sciences
Organization:	Internal Medicine
Journal title:	Arthritis Research & Therapy
Volume:	vol. 21
Issue:	iss. 1
Page start:	p. 54

Faculty of Medical Sciences [65351]
Open Access publications [47646]
Freely accessible full text publications
Electronic publications [74450]
Freely accessible full text publications plus those not yet available due to embargo
Academic publications [165401]
Academic output Radboud University